Skip to Content
Interactive Textbook on Clinical Symptom Research Logo


Home button

Trial Design: Pain Sections
Author Bio
Introduction
Placebo Effects
Single Dose Trials
Repeated Dose Trials
Explanatory Versus Pragmatic
Currently selected section: Dose-Response
Parallel Group Versus Crossover
Conclusion
 

 

Chapter 1: Clinical Trials of Pain Treatment: Dose-Response; Relative Potency; Combinations

 
         

Does this data suggest that Drug S will be a useful additive to morphine?

You answered:

Selection CCannot say. This question can not be answered without more data.


CORRECT

The unanswered question is whether one could get the same enhancement of analgesic with equal or less sedation by giving a higher dose of morphine alone. The addition of a higher morphine dose would convert this to the type of relative potency design discussed above.

The study design illustrated in Figure 6.5, a 2x2 factorial, actually satisfies the requirements for an analgesic combination as specified in the 1992 FDA analgesic development guidelines ((http://www.fda.gov/cder/guidance/old041fn.pdf)), and drug companies have frequently carried out such 2x2 factorial studies. However, the guidelines intended this design to be used for combinations of opioids with anti-inflammatory drugs, whose central nervous system side effects are minimal.